Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Sleep Apnea, Obstructive 5Lung Neoplasms 5Sleep Apnea Syndromes 3Polycystic Ovary Syndrome 3Neoplasms 2Urogenital Neoplasms 1Unilateral Breast Neoplasms 1Thrombocythemia, Essential 1Small Cell Lung Carcinoma 1Polycythemia Vera 1Obesity 1Microcephaly, Primary Autosomal Recessive, 6 1Metabolic Syndrome 1Insulin Resistance 1Glucose Intolerance 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Metformin 28Exercise 8Pioglitazone 7Inositol 6Insulin 5Acupuncture Therapy 4High-Intensity Interval Training 3Ethinyl Estradiol 3salicylsalicylic acid 2drospirenone and ethinyl estradiol combination 2Water 2Tablets 2Surveys and Questionnaires 2Sugars 2Resistance Training 2Folic Acid 2Diet Therapy 2Cyproterone Acetate 2Caloric Restriction 2ziprasidone 1maltodextrin 1lime 1exendin (9-39) 1drospirenone 1cinnulin PF 1adrenosterone 1World Health Organization oral rehydration solution 1Waist-Hip Ratio 1Waist Circumference 1Vitamin D 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Insulin Resistance × Continuous Positive Airway Pressure × Clear all
NCT00203996 2023-03-21

Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

University of Chicago

Phase 4 Terminated
37 enrolled 15 charts

Insulin Resistance, Polycystic Ovary Syndrome, Glucose Intolerance, Sleep Apnea, Obstructive, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡